Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6B
sum of reported positions
Reported positions
306
Changes vs prior quarter
222
12 new · 6 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 258 measured positions in 8 quarters, the typical new or larger position finished −2.7 pts against the S&P 500 and 40% finished ahead of it. For scale, across all 503 funds with a result: −2.1 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
4,204 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors, Capital World Investors, Capital International Investors
6,198 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors, Capital World Investors, Capital International Investors
| Company | Shares | Value | Weight | Of company |
|---|---|---|---|---|
| $206M | 3.4% | 0.05% | ||
| $167M | 2.8% | 0.01% | ||
| $167M | 2.8% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
In its latest 13F, with holdings as of Jun 30, 2026 (Q2 2026), Crawford Investment Counsel Inc reported 306 positions worth $6B. The largest: AbbVie (ABBV), 3.4%; Microsoft (MSFT), 2.8%; Johnson Controls (JCI), 2.8%; PNC Financial Services (PNC), 2.3%; Astrazeneca (AZN), 2.2%. The five largest make up 14% of the reported portfolio.
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.85B | $6B |
| Positions | 300 | 306 |
| Biggest line | — | AbbVie 3% |
1,606 institutions report a stake.
Also among the 20 largest: Dodge & Cox
2,026 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors
1,467 institutions report a stake.
Also among the 20 largest: Investor AB, Capital International Investors, Capital World Investors
1,974 institutions report a stake.
Also among the 20 largest: GQG Partners LLC, Dodge & Cox
| 0.19% |
| $139M | 2.3% | 0.14% |
| $134M | 2.2% | — |
| $132M | 2.2% | 0.18% |
| $130M | 2.2% | 0.05% |
| $125M | 2.1% | 0.04% |
| $123M | 2.0% | 0.32% |
| $119M | 2.0% | 0.12% |
| $119M | 2.0% | 0.02% |
| $118M | 2.0% | 0.13% |
| $116M | 1.9% | — |
| $115M | 1.9% | 0.04% |
| $109M | 1.8% | 0.19% |
| $103M | 1.7% | 0.05% |
| $97.5M | 1.6% | 0.42% |
| $97M | 1.6% | 0.03% |
| $91.3M | 1.5% | 0.46% |
| $88.3M | 1.5% | 0.06% |
| $86.1M | 1.4% | 0.36% |
| $85.6M | 1.4% | 0.03% |
| $82.6M | 1.4% | 0.12% |
| $74.8M | 1.2% | 0.21% |
| $71.7M | 1.2% | 0.00% |
NXP Semiconductors (NXPI)
54K → 55K shares (+2%)
Salesforce (CRM)
93K → 98K shares (+6%)
Accenture (ACN)
497K → 119K shares (−76%)
Power Integrations (POWI)
228K → 176K shares (−23%)
Artisan Partners Asset Management, Inc. (APAM)
529K → 427K shares (−19%)
Walmart (WMT)
126K → 122K shares (−3%)
Valmont Industries (VMI)
25K → 24K shares (−4%)
McCormick & Company (MKC)
249K → 269K shares (+8%)
Expeditors International (EXPD)
83K → 82K shares (−2%)
Humana (HUM)
33K shares
Booking Holdings (BKNG)
2,807 → 72K shares (+2478%)
U.S. Physical Therapy, Inc. (USPH)
152K → 179K shares (+18%)
Academy Sports + Outdoors (ASO)
457K → 242K shares (−47%)
Hexcel (HXL)
113K → 112K shares (−2%)
A10 Networks, Inc. (ATEN)
321K → 296K shares (−8%)
LeMaitre Vascular (LMAT)
112K → 114K shares (+2%)
Independence Realty Trust (IRT)
631K → 645K shares (+2%)
Eli Lilly (LLY)
9,199 → 8,977 shares (−2%)
Gen Digital (GEN)
412K → 422K shares (+2%)
Franklin Electric (FELE)
92K → 98K shares (+7%)
Mueller Water Products (MWA)
451K → 404K shares (−11%)
Cognex (CGNX)
142K → 140K shares (−2%)
Belden Inc. (BDC)
87K → 84K shares (−3%)
Mesa Laboratories Inc (MLAB)
96K → 99K shares (+3%)
South State Bank (SSB)
100K → 98K shares (−1%)
AbbVie (ABBV): $206M, or 3.4% of the portfolio reported for Q2 2026.
Between its last two 13F reports, Crawford Investment Counsel Inc opened 12 new positions, added to 82, trimmed 122 and sold out of 6. The comparison is in share counts, so a price move alone does not count as buying or selling.
Its 13F for Q2 2026 adds up to $6B. That is not the whole firm: a 13F lists only US-listed shares and some options held at the end of the quarter, and leaves out cash, bonds, short positions and foreign holdings.
The report for Q2 2026 was filed on Aug 14, 2026. A manager has 45 days after the end of each quarter to file, so the holdings are always several weeks old when they become public.
On 258 positions it reported as new or larger over 8 quarters, the typical one finished −2.7 points against the S&P 500 after 90 days, and 40% finished ahead of it. Measured from the day each filing became public; history, not a forecast.
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.